I think that is the reasonable number based on the IPO valuation at $500m and GNBT 60% share in that valuation… probably comes in around $2.5. Higher values of course if Excellagen is widely available and even higher if the “Complete Vaccine “ is ready in November… then of course the SP could get stupid …